ZAPELLONI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 135
AS - Asia 80
EU - Europa 70
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 7
AF - Africa 5
Totale 312
Nazione #
US - Stati Uniti d'America 122
SG - Singapore 46
IT - Italia 38
CN - Cina 15
CA - Canada 12
DE - Germania 9
GB - Regno Unito 9
HK - Hong Kong 7
BR - Brasile 6
GR - Grecia 5
IN - India 4
VN - Vietnam 4
FR - Francia 2
KR - Corea 2
MA - Marocco 2
NL - Olanda 2
AO - Angola 1
AT - Austria 1
BD - Bangladesh 1
EC - Ecuador 1
EG - Egitto 1
FI - Finlandia 1
IE - Irlanda 1
JM - Giamaica 1
PL - Polonia 1
RU - Federazione Russa 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 297
Città #
Singapore 26
Ashburn 17
San Jose 17
Santa Clara 11
Council Bluffs 10
Hong Kong 7
Los Angeles 6
Milan 6
Montreal 5
Munich 5
Naples 5
Beijing 4
New York 4
Volos 4
Bari 3
North Bergen 3
Orem 3
Rome 3
São Paulo 3
Atlanta 2
Chicago 2
Düsseldorf 2
Hanoi 2
Hefei 2
Hull 2
Lauterbourg 2
London 2
Palermo 2
Pune 2
Seoul 2
Shanghai 2
Shenzhen 2
Abbeville 1
Aglientu 1
Ankara 1
Bologna 1
Boston 1
Brooklyn 1
Burlington 1
Cachoeirinha 1
Cairo 1
Calgary 1
Charlotte 1
Columbus 1
Conroe 1
Cuenca 1
Dallas 1
Edson 1
Emalahleni 1
Genoa 1
Grandy 1
Hải Dương 1
Itaberaba 1
Lainate 1
Ludhiana 1
Marmirolo 1
Mumbai 1
Naaldwijk 1
New Orleans 1
Newark 1
Nottingham 1
Nuremberg 1
Pembroke 1
Phoenix 1
Pittsburgh 1
Portmore 1
Quart 1
Queens 1
Quảng Ngãi 1
Raleigh 1
Redondo Beach 1
Regina 1
Remanzacco 1
Riverdale 1
Salvador 1
San Antonio 1
Santa Monica 1
Saskatoon 1
Thornhill 1
Toronto 1
Trieste 1
Turku 1
Vienna 1
Totale 219
Nome #
Alectinib for the treatment of papillary thyroid carcinoma harbouring STRN – ALK fusion 101
Molecular biology as a driver in therapeutic choices for ovarian cancer 83
Immunotherapy with anti-PD-1 or PD-L1 in advanced ovarian cancer: A meta-analysis of randomized trials 63
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer 51
Genomic and clinical characterization of estrogen receptor–positive/HER2-negative early breast cancer: Results from the NextGIM study 14
Totale 312
Categoria #
all - tutte 1.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202549 0 0 6 1 1 0 4 5 6 3 11 12
2025/2026150 14 7 6 12 21 14 10 6 23 17 14 6
2026/2027113 7 22 35 40 9 0 0 0 0 0 0 0
Totale 312